97979299 - VERACYTE

Information

  • Trademark
  • 97979299
  • Serial Number
    97979299
  • Filing Date
    February 28, 2023
    a year ago
  • Transaction Date
    December 14, 2024
    22 days ago
  • Status Date
    December 03, 2024
    a month ago
  • Published for Opposition Date
    December 03, 2024
    a month ago
  • Location Date
    November 14, 2024
    a month ago
  • First Use Anywhere Date
    December 14, 2010
    14 years ago
  • First Use In Commerce Date
    December 14, 2010
    14 years ago
  • Status Code
    686
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    LEVINE, HOWARD
  • Attorney Docket Number
    VERAC.052T
    Attorney Name
    Rosaleen H. Chou
    Law Office Assigned Location Code
    M60
  • Owners
Mark Drawing Code
4
Mark Identification
VERACYTE
Case File Statements
  • GS0411: Educational services, namely, providing seminars, workshops, customer trainings and tutorial sessions in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, breast cancer, lung cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Providing online non-downloadable electronic publications in the nature of articles in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, breast cancer, lung cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Providing online non-downloadable reports in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, breast cancer, lung cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases
  • GS0051: Kits for in vitro diagnostic testing for cancers and other diseases; Reagents for medical use; Molecular diagnostic assays for testing of bodily fluids, tissue, cells, blood, disease, cancer, genetics, and pathogens; Diagnostic medical preparations for use in the field of bodily fluids, tissue, cells, blood, disease, cancer, genetics, and pathogens; Diagnostic agents, preparations and substances for medical purposes; Diagnostic test kits consisting primarily of reagents for use in testing bodily fluids, tissue, cells, blood, disease, cancer, genetics, and pathogens; Medical diagnostic test kits consisting primarily of reagents for detecting pathogens; Clinical medical diagnostic reagents, medical diagnostic assays for medical and diagnostic purposes for testing genetic material; Chemicals, assays, reagents and kits consisting primarily of chemicals, assays, and reagents for medical testing and diagnostic purposes in the fields of genomics, diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Medical diagnostic reagents, and kits comprised of medical diagnostic reagents, collection tubes, buffers, tube holders, transport bags, and instruction sheets, for diagnostic testing in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Medical diagnostic testing kits comprised primarily of reagents and assays for use in diagnostics and diagnostic testing in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Tests designed to isolate and extract cells for genetic analysis comprised of reagents for medical diagnostic use
  • GS0011: Reagents for scientific or research use; Diagnostic kits and test kits primarily composed of reagents for determination of genomic and transcriptomic information for scientific or research purposes; Testing kits comprised primarily of preparations, reagents, test strips, collection tubes, buffers, tube holders, transport bags and assays for scientific or research use in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Biological agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use; Diagnostic reagents and preparations, other than for medical and veterinary use; Kits comprised primarily of biological reagents and comprised secondarily of a protocol in the form of printed instructions for use thereof for scientific and research purposes; Tests designed to isolate and extract cells for genetic analysis comprised of reagents for scientific or research purposes; Reagents and molecule or cell markers for scientific or research purposes
  • GS0441: Medical services; Medical diagnostic testing services; Medical testing for diagnostic or treatment purposes; Medical analysis services for diagnostic and treatment purposes; Medical diagnostic testing services in the fields of oncology, cancer, and diseases; Genetic analysis and reporting services for medical diagnostic purposes; Medical diagnostic testing, monitoring and reporting services in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, breast cancer, lung cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Nucleic acid sequencing and analysis services for medical diagnostic and treatment purposes; Genomic and transcriptomic sequencing and analysis services for medical diagnostic and treatment purposes; Genetic analysis and reporting services for medical diagnostic and treatment purposes
  • GS0101: Medical devices, namely, diagnostic instruments for testing bodily fluids, tissue, cells, blood, disease, cancer, genetics, and pathogens; Clinical and medical diagnostic instruments for the testing and analysis of bodily fluids, tissue, cells, blood, disease, cancer, genetics, and pathogens; Anatomic pathology specimen collection kits comprising glass slides, centrifuge tubes, inserts to hold slides and tubes, absorbent cloth, and printed instructions, all for medical use; Apparatus and instruments for use in medical diagnosis and in medical treatment, namely, specimen cups, plastic bags for transmitting medical specimens, and swabs; Clinical, genetic and specialized medical diagnostic test kits comprised primarily of collection tubes, buffers, tube holders, transport bags, shipping containers, and instruction sheets for use in scientific and clinical diagnostic equipment used to detect disease, cancer, genetics, and pathogens
  • GS0421: Clinical medical research; clinical research in the field of genomics, diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research trials and studies, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Scientific laboratory research; Scientific laboratory services; Scientific laboratory testing services for disease, cancer, genetics, and pathogens; Scientific laboratory testing and testing, analysis, monitoring, and results reporting services for use in research and development for oncology, cancers, and diseases; Scientific and medical research and development services; Research and development services for others in the field of diagnostic tests, chemicals, compounds and devices; Research and development of new diagnostic tests, clinical products, diagnostic agents and assays; Nucleic acid sequencing, screening, and analysis services for medical research purposes; Genomic and transcriptomic sequencing, screening, and analysis services for medical research purposes; Genetic analysis and reporting services for medical research purposes; Providing medical research services for others featuring research in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, breast cancer, lung cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Chemical screening analysis and diagnostic services for others for scientific research purposes; Scientific and technological research in the field of genomics, diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases and diagnostic services for scientific research purposes; Advisory, consultative and telephone help desk services relating to the use of assays and reagents for use in biochemical analysis and diagnostic services; Information and advisory services in the fields of medical research, clinical research, medical laboratory research, and scientific research in the fields of laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, breast cancer, lung cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Providing online non-downloadable computer software for medical diagnostics and research in the field of genomics, diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Providing online non-downloadable software for data collection, management, and analysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; Providing online non-downloadable software for use in data analysis in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, breast cancer, lung cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases
Case File Event Statements
  • 11/29/2023 - a year ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/30/2023 - a year ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/3/2023 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 3/19/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/30/2023 - a year ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 2/22/2024 - 10 months ago
    8 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG
  • 5/29/2024 - 7 months ago
    9 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/3/2024 - 6 months ago
    13 - FINAL REFUSAL E-MAILED Type: GNFR
  • 7/3/2024 - 6 months ago
    12 - FINAL REFUSAL WRITTEN Type: CNFR
  • 10/2/2024 - 3 months ago
    16 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG
  • 10/2/2024 - 3 months ago
    15 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR
  • 11/30/2023 - a year ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 5/29/2024 - 7 months ago
    10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/22/2024 - 10 months ago
    7 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR
  • 5/29/2024 - 7 months ago
    11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/3/2024 - 6 months ago
    14 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 10/7/2024 - 3 months ago
    17 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 10/24/2024 - 2 months ago
    25 - USE AMENDMENT FILED Type: IUAF
  • 10/24/2024 - 2 months ago
    23 - DIVISIONAL REQUEST RECEIVED Type: DRRR
  • 10/24/2024 - 2 months ago
    20 - TEAS REQUEST TO DIVIDE RECEIVED Type: ERTD
  • 11/5/2024 - 2 months ago
    22 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 10/7/2024 - 3 months ago
    19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/24/2024 - 2 months ago
    26 - AMENDMENT TO USE PROCESSING COMPLETE Type: AUPC
  • 10/7/2024 - 3 months ago
    18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/24/2024 - 2 months ago
    21 - TEAS AMENDMENT OF USE RECEIVED Type: EAAU
  • 11/8/2024 - a month ago
    24 - DIVISIONAL PROCESSING COMPLETE Type: DPCC
  • 11/27/2024 - a month ago
    29 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 11/12/2024 - a month ago
    27 - USE AMENDMENT ACCEPTED Type: IUAA
  • 11/12/2024 - a month ago
    28 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/3/2024 - a month ago
    31 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 12/3/2024 - a month ago
    30 - PUBLISHED FOR OPPOSITION Type: PUBO